Corex to participate in Quality PharmLog-2018


The 4th International Conference “Quality PharmLog-2018” / “Quality Standards in Pharmaceutical Logistics” will take place in Moscow on November 9, 2018.

For several years now the conference has been bringing together the leading pharmaceutical companies engaged in logistics. This informative event has become the highlight of the year which cannot be overlooked by pharmaceutical logistics experts. Among the participants of the conference there will be representatives of the Society of Professional Pharmaceutical Organizations (SPFO), Association of the Russian Pharmaceutical Manufacturers (ARFP), Russian Register of Medicines (RLS), and Russian Export Center. The event will be covered by the leading industry newspaper and the news portal “PharmVestnik” as well as by other leading media.

The list of speakers includes representatives of Roszdravnadzor, SPFO, RNC Pharma, Johnson & Johnson, Pfizer, and COREX.

Vitaliy Shakhnazarov, Quality Director, COREX, will share a presentation titled “Clinical trial logistics. Continuous monitoring of supply chain conditions and specifics of logistical operations with investigational drugs”.

We look forward to connecting with our colleagues, partners, and representatives of state institutions as well as experts in the field of clinical logistics, to learn from them and to share our unique expertise”.

To schedule a meeting with COREX representatives in order to discuss potential cooperation, please contact our BD team.



09 November, 2018


09 November, 2018


Back to the list

Industry insights

CPhI Worldwide 2018

COREX representatives will be attending CPhI Worldwide 2018.

Annual results 2019 of CT market: ACT...

The Association of Clinical Trials Organizations (ACTO) (Russia) recently published an overview of clinical trials market in 2019.

Clinical trials and delivery in post-...

The pharmaceutical industry has faced numerous challenges since the beginning of 2021 including the rush to supply COVID-19 vaccines. The start of the year also saw the departure of the UK from the EU and theEuropean Medicines Agency (EMA). The Medicines and Healthcare Products Regulatory Agency (MHRA) is now fully in charge of all regulatory matters, oversight of clinical research and approval of medicines.


We’re here to help.
Email us at or use our feedback form to send us your question.

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy. Read More.